Rovalpituzumab tesirine Completed Phase 3 Trials for Small Cell Lung Cancer (SCLC) Treatment

CompletedTreatment3 IdentifierTitleDrugs
NCT03061812Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)